Alan L. Weiner
38Patents
23h-index
49Co-inventors
85Inventor score
Filing activity: Mar 24, 1983 → Mar 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5466233A | Tack for intraocular drug delivery and method for inserting and removing same | Human Necessities | 321 | Expired |
| US4708861A | Liposome-gel compositions | Emerging Cross-Sectional Technologies | 216 | Expired |
| US4610868A | Lipid matrix carriers for use in drug delivery systems | Emerging Cross-Sectional Technologies | 201 | Expired |
| US5322691A | Ocular insert with anchoring protrusions | Human Necessities | 162 | Expired |
| US4721612A | Steroidal liposomes | Emerging Cross-Sectional Technologies | 136 | Expired |
| US5154930A | Pharmacological agent-lipid solution preparation | Emerging Cross-Sectional Technologies | 110 | Expired |
| US5059591A | Drug preparations of reduced toxicity | Human Necessities | 100 | Expired |
| US6090406A | Potentiation of immune responses with liposomal adjuvants | Emerging Cross-Sectional Technologies | 100 | Expired |
| US5395618A | Ocular insert with anchoring protrusions | Human Necessities | 86 | Expired |
| US6759057B1 | Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5989579A | Ocular insert with anchoring protrusions | Human Necessities | 63 | Expired |
| US4897384A | Drug preparations of reduced toxicity | Human Necessities | 61 | Expired |
| US5049392A | Osmotically dependent vesicles | Emerging Cross-Sectional Technologies | 59 | Expired |
| US5041278A | Alpha tocopherol-based vesicles | Emerging Cross-Sectional Technologies | 56 | Expired |
| US4891208A | Steroidal liposomes | Emerging Cross-Sectional Technologies | 53 | Expired |
| US6011062A | Storage-stable prostaglandin compositions | Human Necessities | 51 | Expired |
| US5916588A | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use | Human Necessities | 50 | Expired |
| US5200393A | Lipid excipient for nasal delivery and topical application | Chemistry; Metallurgy | 40 | Expired |
| US6235781A | Prostaglandin product | Human Necessities | 38 | Expired |
| US4861580A | Composition using salt form of organic acid derivative of alpha-tocopheral | Emerging Cross-Sectional Technologies | 35 | Expired |
| US6352716B1 | Steroidal liposomes | Emerging Cross-Sectional Technologies | 33 | Expired |
| US4668638A | Liposome composition for lupus assay | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5171737A | Emulsions | Human Necessities | 24 | Expired |
| US5366958A | Localized delivery using fibronectin conjugates | Emerging Cross-Sectional Technologies | 23 | Expired |
| US4564599A | Liposome composition for lupus assay | Emerging Cross-Sectional Technologies | 22 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.